Allosteric modulation of drug binding to human serum albumin.
about
Ibuprofen impairs allosterically peroxynitrite isomerization by ferric human serum heme-albuminA structure-based model for predicting serum albumin bindingA principal component analysis of the dynamics of subdomains and binding sites in human serum albumin.Characterization of the binding of sulfonylurea drugs to HSA by high-performance affinity chromatography.The effects of glycation on the binding of human serum albumin to warfarin and L-tryptophan.The five-to-six-coordination transition of ferric human serum heme-albumin is allosterically-modulated by ibuprofen and warfarin: a combined XAS and MD studyChromatographic analysis of acetohexamide binding to glycated human serum albuminBinding of tolbutamide to glycated human serum albuminUse of peak decay analysis and affinity microcolumns containing silica monoliths for rapid determination of drug-protein dissociation rates.Reciprocal allosteric modulation of carbon monoxide and warfarin binding to ferrous human serum heme-albuminDesign and characterization of protein-quercetin bioactive nanoparticles.Characterization of interaction kinetics between chiral solutes and human serum albumin by using high-performance affinity chromatography and peak profilingAnalysis of the structure and dynamics of human serum albumin.Stabilization of Human Serum Albumin by the Binding of Phycocyanobilin, a Bioactive Chromophore of Blue-Green Alga Spirulina: Molecular Dynamics and Experimental Study.Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties.Stereoselective binding of chiral drugs to plasma proteinsEvaluation of alternatives to warfarin as probes for Sudlow site I of human serum albumin: characterization by high-performance affinity chromatographyInteractive association of drugs binding to human serum albumin.Serum Albumin Binding and Esterase Activity: Mechanistic Interactions with Organophosphates.Improved dialytic removal of protein-bound uraemic toxins with use of albumin binding competitors: an in vitro human whole blood studyBiomolecular interaction study of Cyclolinopeptide A with human serum albumin.Role of block copolymer-micelle nanocomposites in dye-bovine serum albumin binding: a combined experimental and molecular docking study.Modulation of heme and myristate binding to human serum albumin by anti-HIV drugs. An optical and NMR spectroscopic study.Reductive nitrosylation of ferric human serum heme-albumin.Binding of δ9-tetrahydrocannabinol and diazepam to human serum albumin.
P2860
Q24652314-2D8629E5-1DF0-4CA1-A248-A9029765C75EQ28541718-F131AAD3-E2DC-44CE-8FDB-86A738EC5D20Q30354480-7228DC51-EE33-406C-BEFB-9CFDE4704B1BQ33876316-FB00B442-0148-4302-88A3-8F5C5569F977Q34009043-DC1BCF84-9B44-43D4-8B48-215027DC4B47Q34083630-EE6C9E73-93A3-4D6A-92D4-7AA4A3AF9247Q34189372-B75E3CF7-B918-42A5-8396-8F88EB88A0F8Q34233297-C1A55BA4-F2FE-4E83-8739-DC1B47249576Q34507719-C651EA13-E31F-4DEB-B765-B710BFB40F2DQ34650567-9B30A697-F8FF-4BF9-B66D-D40595BB5A44Q35049363-33394406-23F7-4827-8685-6DF86C3F04CEQ35212114-A156D391-3E90-45D0-B253-278CEB06FFA0Q35267051-6805750B-2672-4069-9F2A-3FD6A25F2C89Q36222212-3DB20975-CCC2-46D7-84B5-618EB9F68758Q36807461-345F90B3-0EC2-4155-9BEB-4D04D4591A93Q37069257-10C912F8-B4BC-4118-B2FB-4B6EEED24AC7Q37216845-FBA3D37A-764C-4A1E-B6E1-DC303BF778B0Q38192435-65A5C30D-CBB7-4051-98FB-9CF3596B33CBQ38674145-F697F3D6-DE29-4F2B-8CA1-9546A38F86C1Q39309486-97C272D7-8014-430E-B031-213F888A6AAEQ42042555-5FA28486-62C7-4C72-9D5E-19E6ADDBB300Q43494240-D1EE9DD2-92D9-499E-93E7-2143129DFD6BQ44294189-BB6FE056-EB42-43B3-A668-99DAF0BF7077Q46368772-2CE1C26C-5BC7-4CFE-B3F8-704EA4832B2AQ48264927-94B45234-BA0D-421F-859F-45BC1ACF46B2
P2860
Allosteric modulation of drug binding to human serum albumin.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Allosteric modulation of drug binding to human serum albumin.
@ast
Allosteric modulation of drug binding to human serum albumin.
@en
type
label
Allosteric modulation of drug binding to human serum albumin.
@ast
Allosteric modulation of drug binding to human serum albumin.
@en
prefLabel
Allosteric modulation of drug binding to human serum albumin.
@ast
Allosteric modulation of drug binding to human serum albumin.
@en
P2093
P1476
Allosteric modulation of drug binding to human serum albumin
@en
P2093
Alessio Bocedi
Gabriella Fanali
Paolo Ascenzi
Riccardo Fesce
Stefania Notari
P304
P356
10.2174/138955706776361448
P50
P577
2006-04-01T00:00:00Z